Just some pondering on KZAKZA SHARE PRICE TO MARKET CAPITALISATION RATIO
As at Jujy 6, 2022
The share price of $0.625 (62.5 cents) equates to $86.72M market cap.
Therefore the SP of $1 equals to $139M market cap.
A market cap of $1B equates to the share price being $7.20
A market cap of $2B equates to the share price being $14.40
A market cap of $5B equates to the share price being $36
What would happen to the share price if KZA went it alone in marketing pAX. The estimate is that there could be sales of up to $1.5B pa. Lets assume a 30% net profit on reduced sales of $1B for an annual net profit of $300M
A $300M pa net profit would value KZA at say a multiple of 10 times for a market cap of $3B which would equate to a SP of $21.60.
This probably means that a big bio company (Genetech etc ) would have to offer $3B for pAX
Obviously there are other values associated with pAX especially BCBM & DIPG, plus the voucher, and EVT-801
An early $5B takeover deal would be possible. SP could be $36 for such a take over deal.
- Forums
- ASX - By Stock
- KZA SP / MC Ratio
Just some pondering on KZAKZA SHARE PRICE TO MARKET...
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online